Fine definition of the CXCR4-binding region on the V3 loop of feline immunodeficiency virus surface glycoprotein

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Hu, Qiong Ying ^a   Fink, Elizabeth ^a   Hong, Yang ^a   Wang, Cathy ^a   Grant, Chris K ^b   Elder, John H ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Custom Monoclonals International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CD134 ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; FELINE IMMUNODEFICIENCY VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RESIDUE ANALYSIS; SITE DIRECTED MUTAGENESIS; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS ENVELOPE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ANTIBODIES, MONOCLONAL; BINDING SITES; CATS; CELL LINE; CELL MEMBRANE; HUMANS; IMMUNODEFICIENCY VIRUS, FELINE; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDES; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, CXCR4; RECEPTORS, OX40; VIRAL PROTEINS; VIRUS INTERNALIZATION;

FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77956292410     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010689     Document Type: Article

References (49)

1. Pedersen NC, Ho EW, Brown ML, Yamamoto JK (1987) Isolation of a Tlymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235: 790-3.
2. Elder JH, Sundstrom M, de Rozieres S, de Parseval A, Grant CK, et al. (2008) Molecular mechanisms of FIV infection. Vet Immunol Immunopathol 123: 3-13.
3. Podell M, Buck WR, Hayes KA, Gavrilin MA, Mathes LE (2002) Animal models of retroviral encephalopathies: feline model. Curr Protoc Neurosci 9: Unit 9.9.
4. Uhl EW, Martin M, Coleman JK, Yamamoto JK (2008) Advances in FIV vaccine technology. Vet Immunol Immunopathol 123: 65-80.
5. Willett BJ, Hosie MJ (2008) Chemokine receptors and co-stimulatory molecules:unravelling feline immunodeficiency virus infection. Vet Immunol Immunopathol 123: 56-64.
6. de Parseval A, Chatterji U, Sun P, Elder JH (2004) Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor. Proc Natl Acad Sci U S A 101: 13044-9.
7. Shimojima M, Miyazawa T, Ikeda Y, McMonagle EL, Haining H, et al. (2004) Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science 303: 1192-5.
8. Willett BJ, Picard L, Hosie MJ, Turner JD, Adema K, et al. (1997) Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J Virol 71: 6407-15.
9. de Parseval A, Elder JH (2001) Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor. J Virol 75: 4528-39.
10. Richardson J, Pancino G, Merat R, Leste-Lasserre T, Moraillon A, et al. (1999) Shared usage of the chemokine receptor CXCR4 by primary and laboratoryadapted strains of feline immunodeficiency virus. J Virol 73: 3661-71.
11. Willett BJ, Adema K, Heveker N, Brelot A, Picard L, et al. (1998) The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus. J Virol 72: 6475-81.
12. Brelot A, Heveker N, Adema K, Hosie MJ, Willett B, et al. (1999) Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses. J Virol 73: 2576-86.
13. Picard L, Wilkinson DA, McKnight A, Gray PW, Hoxie JA, et al. (1997) Role of the amino-terminal extracellular domain of CXCR-4 in human immunodeficiency virus type 1 entry. Virology 231: 105-11.
14. Rosenkilde MM, Gerlach LO, Jakobsen JS, Skerlj RT, Bridger GJ, et al. (2004) Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor: transfer of binding site to the CXCR3 receptor. J Biol Chem 279: 3033-41.
15. Hatse S, Princen K, Vermeire K, Gerlach LO, Rosenkilde MM, et al. (2003) Mutations at the CXCR4 interaction sites for AMD3100 influence anti-CXCR4 antibody binding and HIV-1 entry. FEBS Lett 546: 300-6.
16. Chabot DJ, Zhang PF, Quinnan GV, Broder CC (1999) Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates. J Virol 73: 6598-609.
17. Ling H, Usami O, Xiao P, Gu HX, Hattori T (2004) The N-terminal of the V3 loop in HIV type 1 gp120 is responsible for its conformation-dependent interaction with cell surface molecules. AIDS Res Hum Retroviruses 20: 213-8.
18. Hartley O, Klasse PJ, Sattentau QJ, Moore JP (2005) V3: HIV's switch-hitter. AIDS Res Hum Retroviruses 21: 171-89.
19. Rusche JR, Javaherian K, McDanal C, Petro J, Lynn DL, et al. (1988) Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc Natl Acad Sci U S A 85: 3198-202.
20. Wu L, Gerard NP, Wyatt R, Choe H, Parolin C, et al. (1996) CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384: 179-83.
21. Trkola A, Dragic T, Arthos J, Binley JM, Olson WC, et al. (1996) CD4- dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 384: 184-7.
22. Dittmar MT, McKnight A, Simmons G, Clapham PR, Weiss RA, et al. (1997) HIV-1 tropism and co-receptor use. Nature 385: 495-6.
23. Fouchier RA, Groenink M, Kootstra NA, Tersmette M, Huisman HG, et al. (1992) Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol 66: 3183-7.
24. Cardozo T, Kimura T, Philpott S, Weiser B, Burger H, et al. (2007) Structural basis for coreceptor selectivity by the HIV type 1 V3 loop. AIDS Res Hum Retroviruses 23: 415-26.
25. Morikawa S, Lutz H, Aubert A, Bishop DH (1991) Identification of conserved and variable regions in the envelope glycoprotein sequences of two feline immunodeficiency viruses isolated in Zurich, Switzerland. Virus Res 21: 53-63.
26. Pancino G, Ellerbrok H, Sitbon M, Sonigo P (1994) Conserved framework ofenvelope glycoproteins among lentiviruses. Curr Top Microbiol Immunol 188: 77-105.
27. Pancino G, Fossati I, Chappey C, Castelot S, Hurtrel B, et al. (1993) Structure and variations of feline immunodeficiency virus envelope glycoproteins. Virology 192: 659-62.
28. Phillips TR, Talbott RL, Lamont C, Muir S, Lovelace K, et al. (1990) Comparison of two host cell range variants of feline immunodeficiency virus. J Virol 64: 4605-13.
29. Siebelink KH, Chu IH, Rimmelzwaan GF, Weijer K, Osterhaus AD, et al. (1992) Isolation and partial characterization of infectious molecular clones of feline immunodeficiency virus obtained directly from bone marrow DNA of a naturally infected cat. J Virol 66: 1091-7.
30. Sundaravaradan V, Das SR, Ramakrishnan R, Sehgal S, Gopalan S, et al. (2007) Role of HIV-1 subtype C envelope V3 to V5 regions in viral entry, coreceptor utilization and replication efficiency in primary T-lymphocytes and monocyte-derived macrophages. Virol J 4: 126.
31. Sander O, Sing T, Sommer I, Low AJ, Cheung PK, et al. (2007) Structural descriptors of gp120 V3 loop for the prediction of HIV-1 coreceptor usage. PLoS Comput Biol 3: e58. doi:10.1371/journal.pcbi.0030058.
32. Hwang SS, Boyle TJ, Lyerly HK, Cullen BR (1991) Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 253: 71-4
33. Huang CC, Tang M, Zhang MY, Majeed S, Montabana E, et al. (2005) Structure of a V3-containing HIV-1 gp120 core. Science 310: 1025-8.
34. LaRosa GJ, Davide JP, Weinhold K, Waterbury JA, Profy AT, et al. (1990) Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science 249: 932-5.
35. Basmaciogullari S, Babcock GJ, Van Ryk D, Wojtowicz W, Sodroski J (2002) Identification of conserved and variable structures in the human immunodeficiency virus gp120 glycoprotein of importance for CXCR4 binding. J Virol 76: 10791-800.
36. Sundstrom M, White RL, de Parseval A, Sastry KJ, Morris G, et al. (2008) Mapping of the CXCR4 binding site within variable region 3 of the feline immunodeficiency virus surface glycoprotein. J Virol 82: 9134-42.
37. McKnight A, Wilkinson D, Simmons G, Talbot S, Picard L, et al. (1997) Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent. J Virol 71: 1692-6.
38. Willett BJ, Cannon CA, Hosie MJ (2002) Upregulation of surface feline CXCR4 expression following ectopic expression of CCR5: implications for studies of the cell tropism of feline immunodeficiency virus. J Virol 76: 9242-52.
39. Willett BJ, Hosie MJ, Neil JC, Turner JD, Hoxie JA (1997) Common mechanism of infection by lentiviruses. Nature 385: 587.
40. Baribaud F, Edwards TG, Sharron M, Brelot A, Heveker N, et al. (2001) Antigenically distinct conformations of CXCR4. J Virol 75: 8957-67.
41. de Parseval A, Ngo S, Sun P, Elder JH (2004) Factors that increase the effective concentration of CXCR4 dictate feline immunodeficiency virus tropism and kinetics of replication. J Virol 78: 9132-43.
42. de Parseval A, Grant CK, Sastry KJ, Elder JH (2006) Sequential CD134- CXCR4 interactions in feline immunodeficiency virus (FIV): soluble CD134 activates FIV Env for CXCR4-dependent entry and reveals a cryptic neutralization epitope. J Virol 80: 3088-91.
43. Elder JH, Lin YC, Fink E, Grant CK (2010) Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV. Curr HIV Res 8: 73-80.
44. Moore JP, Sattentau QJ, Wyatt R, Sodroski J (1994) Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies. J Virol 68: 469-84.
45. de Parseval A, Chatterji U, Morris G, Sun P, Olson AJ, et al. (2005) Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus. Nat Struct Mol Biol 12: 60-6.
46. Lerner DL, Grant CK, de Parseval A, Elder JH (1998) FIV infection of IL-2- dependent and -independent feline lymphocyte lines: host cells range distinctions and specific cytokine upregulation. Vet Immunol Immunopathol 65: 277-97.
47. Sundstrom M, Chatterji U, Schaffer L, de Rozières S, Elder JH (2008) Feline immunodeficiency virus OrfA alters gene expression of splicing factors and proteasome-ubiquitination proteins. Virology 371: 394-404.
48. de Parseval A, Lerner DL, Borrow P, Willett BJ, Elder JH (1997) Blocking of feline immunodeficiency virus infection by a monoclonal antibody to CD9 is via inhibition of virus release rather than interference with receptor binding. J Virol 71: 5742-9.
49. Johnston JC, Gasmi M, Lim LE, Elder JH, Yee JK, et al. (1999) Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J Virol 73: 4991-5000.